We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
NVQDB | NoviqTech Limited | 0.03 | 0.025 | 500.00% | 62,638 | 3 |
CBHOA | Coolabah Metals Ltd | 0.05 | 0.029 | 138.10% | 134,250 | 2 |
CBHO | Coolabah Metals Ltd | 0.02 | 0.011 | 122.22% | 300,000 | 1 |
GMLO | Gateway Mining Ltd | 0.015 | 0.008 | 114.29% | 950,000 | 6 |
JAY | Jayride Group Limited | 0.016 | 0.008 | 100.00% | 804,921 | 13 |
GMNO | Gold Mountain Limited | 0.002 | 0.001 | 100.00% | 1,000,000 | 2 |
BCK | Brockman Mining Ltd | 0.023 | 0.008 | 53.33% | 2,068,556 | 32 |
YPB | YPB Group Ltd | 0.003 | 0.001 | 50.00% | 667,244 | 7 |
ARDO | Argent Minerals Ltd | 0.006 | 0.002 | 50.00% | 83,333 | 1 |
BUYO | Bounty Oil & Gas | 0.003 | 0.001 | 50.00% | 200,000 | 1 |
8VI | 8VI Holdings Limited | 0.10 | 0.03 | 42.86% | 15,264 | 13 |
TORONTO, June 06, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that on June 4, 2024, it was notified by the Nasdaq Stock Market LLC (“Nasdaq”) that the Company had regained compliance with the stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) (“Minimum Equity Requirement”). Pursuant to Nasdaq Listing Rule 5815(d)(4)(B), the Company will be subject to a mandatory panel monitor through June 4, 2025. The Nasdaq Staff originally issued the Company a deficiency notice on May 31, 2023, citing that stockholders’ ...
JERUSALEM, June 7, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) (the "Company"), a biotechnology company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today announced that on June 5, 2024, it received formal notification from the Listing Qualification Department (the "Staff") of the Nasdaq Stock Market ("Nasdaq") that the Company has regained compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule").
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that the U.S. Food and Drug Administration (FDA) has approved RYTELO™ (imetelstat) for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent (TD) anemia requiring four or more red blood cell units over eight weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA).
Semtech Corporation (“Semtech” or the “Company”) (Nasdaq: SMTC), a high-performance semiconductor, IoT systems, and connectivity service provider, today announced the appointment of Dr. Hong Q. Hou, a current member of the Semtech Board of Directors, as President and Chief Executive Officer, effective June 6, 2024. Dr. Hou’s appointment follows Paul H. Pickle’s departure as President and Chief Executive Officer.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 70,962.91 | 198.89 | 0.28% | 1.4T | 3,781,776,825 |
ETH | Ethereum | 3,792.33 | -18.94 | -0.50% | 455.48B | 1,699,693,694 |
BNB | Binance Coin | 699.50 | -10.97 | -1.54% | 110.13B | 479,561,789 |
USDT | Tether USD | 0.99918 | -0.00043 | -0.04% | 97.76B | 263,069,481 |
SOL | Solana | 169.64 | -0.310 | -0.18% | 74.67B | 666,797,250 |
STETH | stETH | 3,788.65 | -20.33 | -0.53% | 36.98B | 4,866,774 |
XRP | Ripple | 0.523 | 0.0016 | 0.31% | 28.55B | 249,203,869 |
USDC | USD Coin | 0.9998 | 0.00 | 0.00% | 28.07B | 823,780,632 |
TONCOIN | Wrapped TON Coin | 7.49 | -0.003212 | -0.04% | 25.97B | 180,197,439 |
DOGE | Dogecoin | 0.15945 | -0.00058 | -0.36% | 22.87B | 227,032,067 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions